MetaADEDB 2.0 @ LMMD
Thyroxine
(YDTFRJLNMPSCFM-YDALLXLXSA-M)
Structure
SMILES
[O-]C(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N.[Na+]
Molecular Formula:
C15H10I4NNaO4
Molecular Weight:
798.852
Log P:
3.9229
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
95.61
CAS Number(s):
55-03-8; 1491-91-4; 25416-65-3; 50809-32-0
Synonym(s)
1.
Thyroxine
2.
L-Thyroxine
3.
Levothyroxine
4.
T4 Thyroid Hormone
5.
3,5,3',5'-Tetraiodothyronine
6.
Berlthyrox
7.
Dexnon
8.
Eferox
9.
Eltroxin
10.
Eltroxine
11.
Euthyrox
12.
Eutirox
13.
L-3,5,3',5'-Tetraiodothyronine
14.
L-Thyrox
15.
L-Thyroxin Henning
16.
L-Thyroxin beta
17.
L-Thyroxine Roche
18.
Levo-T
19.
Levothroid
20.
Levothyroid
21.
Levothyroxin Deladande
22.
Levothyroxin Delalande
23.
Levothyroxine Sodium
24.
Levoxine
25.
Levoxyl
26.
Lévothyrox
27.
Novothyral
28.
Novothyrox
29.
O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine
30.
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
31.
Oroxine
32.
Sodium Levothyroxine
33.
Synthroid
34.
Synthrox
35.
Thevier
36.
Thyrax
37.
Thyroxin
38.
Tiroidine
39.
Tiroxina Leo
40.
Unithroid
41.
L Thyrox
42.
L Thyroxin Henning
43.
L Thyroxin beta
44.
L Thyroxine
45.
L Thyroxine Roche
46.
Levo T
47.
Thyroid Hormone, T4
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 5383
Canada Vigilance: 7
Canada Vigilance
US FAERS
2HeadacheFAERS: 3165
Canada Vigilance: 4
Canada Vigilance
US FAERS
3VertigoFAERS: 1935US FAERS
4AlopeciaFAERS: 1790
Canada Vigilance: 4
Canada Vigilance
US FAERS
5AstheniaFAERS: 1725
Canada Vigilance: 4
Canada Vigilance
US FAERS
6Blood thyroid stimulating hormone increasedFAERS: 1622
Canada Vigilance: 3
Canada Vigilance
US FAERS
7DizzinessFAERS: 1608
Canada Vigilance: 10
Canada Vigilance
US FAERS
8MyalgiaFAERS: 1591US FAERS
9NauseaFAERS: 1454
Canada Vigilance: 2
Canada Vigilance
US FAERS
10ArthralgiaFAERS: 1435US FAERS
11PalpitationsFAERS: 1403
Canada Vigilance: 4
Canada Vigilance
US FAERS
12AnxietyFAERS: 1057
Canada Vigilance: 1
Canada Vigilance
US FAERS
13MalaiseFAERS: 1056
Canada Vigilance: 10
Canada Vigilance
US FAERS
14Blood thyroid stimulating hormone decreasedFAERS: 910US FAERS
15Diffuse alopeciaFAERS: 874US FAERS
16Loss of personal independence in daily activitiesFAERS: 798US FAERS
17HyperthyroidismFAERS: 773
Canada Vigilance: 2
Canada Vigilance
US FAERS
18AmnesiaFAERS: 734
Canada Vigilance: 1
Canada Vigilance
US FAERS
19TachycardiaFAERS: 680
Canada Vigilance: 1
Canada Vigilance
US FAERS
20PainFAERS: 640
Canada Vigilance: 2
Canada Vigilance
US FAERS
21Weight decreasedFAERS: 592
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Feeling abnormalFAERS: 582
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Product formulation issueFAERS: 581US FAERS
24Blood thyroid stimulating hormone normalFAERS: 556US FAERS
25ConstipationFAERS: 546US FAERS
26Abdominal PainFAERS: 540
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Memory impairmentFAERS: 518
Canada Vigilance: 1
Canada Vigilance
US FAERS
28TremorFAERS: 493
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Drug ineffectiveFAERS: 489
Canada Vigilance: 9
Canada Vigilance
US FAERS
30NervousnessFAERS: 477
Canada Vigilance: 1
Canada Vigilance
US FAERS
31SomnolenceFAERS: 450
Canada Vigilance: 3
Canada Vigilance
US FAERS
32PruritusFAERS: 422
Canada Vigilance: 3
Canada Vigilance
US FAERS
33Visual ImpairmentFAERS: 404
Canada Vigilance: 1
Canada Vigilance
US FAERS
34HypothyroidismFAERS: 389
Canada Vigilance: 7
Canada Vigilance
US FAERS
35Mood swingsFAERS: 379US FAERS
36VomitingFAERS: 373
Canada Vigilance: 2
Canada Vigilance
US FAERS
37Depressed moodFAERS: 369US FAERS
38Impaired work abilityFAERS: 346US FAERS
39DyspepsiaFAERS: 317US FAERS
40Blood thyroid stimulating hormoneFAERS: 314US FAERS
41ApathyFAERS: 312US FAERS
42Chest PainFAERS: 308
Canada Vigilance: 2
Canada Vigilance
US FAERS
43Maternal exposure during pregnancyFAERS: 302US FAERS
44Blood thyroid stimulating hormone abnormalFAERS: 293
Canada Vigilance: 1
Canada Vigilance
US FAERS
45CryingFAERS: 288
Canada Vigilance: 1
Canada Vigilance
US FAERS
46StressFAERS: 267US FAERS
47Dry skinFAERS: 246
Canada Vigilance: 1
Canada Vigilance
US FAERS
48HypotensionFAERS: 228US FAERS
49Impaired driving abilityFAERS: 226US FAERS
50TinnitusFAERS: 220
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Feeling ColdFAERS: 219
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Personal relationship issueFAERS: 208US FAERS
53Back PainFAERS: 204US FAERS
54HypersensitivityFAERS: 194
Canada Vigilance: 2
Canada Vigilance
US FAERS
55Chest discomfortFAERS: 193
Canada Vigilance: 2
Canada Vigilance
US FAERS
56General physical health deteriorationFAERS: 191US FAERS
57UrticariaFAERS: 183
Canada Vigilance: 5
Canada Vigilance
US FAERS
58AngerFAERS: 176US FAERS
59Psychiatric symptomFAERS: 169US FAERS
60Product quality issueFAERS: 160
Canada Vigilance: 4
Canada Vigilance
US FAERS
61Emotional distressFAERS: 156US FAERS
62Product substitution issueFAERS: 148
Canada Vigilance: 4
Canada Vigilance
US FAERS
63AgitationFAERS: 138US FAERS
64Musculoskeletal stiffnessFAERS: 137US FAERS
65Angina PectorisFAERS: 128US FAERS
66Blood cholesterol increasedFAERS: 124US FAERS
67Abdominal discomfortFAERS: 116
Canada Vigilance: 4
Canada Vigilance
US FAERS
68Gastrointestinal motility disorderFAERS: 113US FAERS
69ImpatienceFAERS: 111US FAERS
70Musculoskeletal PainFAERS: 111US FAERS
71DiscomfortFAERS: 110US FAERS
72Gastrointestinal PainFAERS: 109US FAERS
73HypokinesiaFAERS: 109US FAERS
74Feeling jitteryFAERS: 107
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Eye painFAERS: 106
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Night sweatsFAERS: 106US FAERS
77AphasiaFAERS: 103US FAERS
78ChillsFAERS: 103US FAERS
79Neck PainFAERS: 102US FAERS
80SyncopeFAERS: 102US FAERS
81Poor quality sleepFAERS: 100US FAERS
82DysgeusiaFAERS: 98US FAERS
83Middle insomniaFAERS: 98US FAERS
84Pharmaceutical product complaintFAERS: 98US FAERS
85FlatulenceFAERS: 97US FAERS
86Live BirthFAERS: 95US FAERS
87Negative thoughtsFAERS: 95US FAERS
88OnychoclasisFAERS: 93
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Peripheral swellingFAERS: 93US FAERS
90SwellingFAERS: 93US FAERS
91Burning sensationFAERS: 85US FAERS
92Temperature intoleranceFAERS: 85US FAERS
93DysphoniaFAERS: 84
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Emotional disorderFAERS: 84US FAERS
95Mental impairmentFAERS: 84US FAERS
96Bone painFAERS: 83US FAERS
97TensionFAERS: 83US FAERS
98FormicationFAERS: 82US FAERS
99Limb discomfortFAERS: 82US FAERS
100OverdoseFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
101Gamma-Glutamyltransferase IncreasedFAERS: 81US FAERS
102PresyncopeFAERS: 80US FAERS
103LethargyFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Blood triglycerides increasedFAERS: 77US FAERS
105Joint swellingFAERS: 77US FAERS
106Anti-thyroid antibody positiveFAERS: 74US FAERS
107Reaction to drug excipientsFAERS: 72US FAERS
108ErythemaFAERS: 68US FAERS
109Atrial FibrillationFAERS: 67US FAERS
110Mental FatigueFAERS: 67US FAERS
111Adverse eventFAERS: 66US FAERS
112Diabetes MellitusFAERS: 65US FAERS
113HypersomniaFAERS: 63US FAERS
114Throat irritationFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Head discomfortFAERS: 62US FAERS
116ThirstFAERS: 62US FAERS
117Abnormal weight gainFAERS: 58US FAERS
118Blood glucose increasedFAERS: 58US FAERS
119BradycardiaFAERS: 57US FAERS
120Eye irritationFAERS: 55US FAERS
121Oropharyngeal painFAERS: 55
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Feeling of body temperature changeFAERS: 54US FAERS
123Initial insomniaFAERS: 54US FAERS
124AngioedemaFAERS: 53US FAERS
125Incorrect dose administeredFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Unevaluable eventFAERS: 52US FAERS
127EczemaFAERS: 50US FAERS
128Gait inabilityFAERS: 50US FAERS
129Medication ErrorFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Cerebrovascular accidentFAERS: 49US FAERS
131ChokingFAERS: 47US FAERS
132Drug dispensing errorFAERS: 47US FAERS
133Drug dose omissionFAERS: 45US FAERS
134Sense of oppressionFAERS: 45US FAERS
135Suicide attemptFAERS: 45US FAERS
136Therapeutic response unexpected with drug substitutionFAERS: 45US FAERS
137AsthmaFAERS: 44US FAERS
138FlushingFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
139Muscle FatigueFAERS: 42US FAERS
140ExophthalmosFAERS: 40US FAERS
141Alanine Aminotransferase IncreasedFAERS: 38US FAERS
142HyperacusisFAERS: 38US FAERS
143DehydrationFAERS: 37US FAERS
144RestlessnessFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
145SluggishnessFAERS: 36US FAERS
146BedriddenFAERS: 35US FAERS
147DisorientationFAERS: 35US FAERS
148Drug level above therapeuticFAERS: 35US FAERS
149AcneFAERS: 34US FAERS
150Fear of fallingFAERS: 34US FAERS
151MalabsorptionFAERS: 34US FAERS
152ArthropathyFAERS: 33US FAERS
153Activities of daily living impairedFAERS: 32US FAERS
154AsphyxiaFAERS: 32US FAERS
155BlindnessFAERS: 32US FAERS
156MenorrhagiaFAERS: 32US FAERS
157Musculoskeletal discomfortFAERS: 32US FAERS
158PhotophobiaFAERS: 32US FAERS
159Urinary tract infectionFAERS: 32US FAERS
160Cold sweatFAERS: 31US FAERS
161Renal painFAERS: 31US FAERS
162Aspartate Aminotransferase IncreasedFAERS: 30US FAERS
163Blood pressure fluctuationFAERS: 30US FAERS
164Myocardial InfarctionFAERS: 30US FAERS
165NasopharyngitisFAERS: 30US FAERS
166Reaction to excipientFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Toxicity to various agentsFAERS: 30US FAERS
168Therapeutic response unexpectedFAERS: 29US FAERS
169DiplopiaFAERS: 28US FAERS
170Tri-iodothyronine free decreasedFAERS: 28US FAERS
171Wrong technique in product usage processFAERS: 28US FAERS
172Diabetes mellitus inadequate controlFAERS: 27US FAERS
173EructationFAERS: 27US FAERS
174Lip swellingFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Low density lipoprotein increasedFAERS: 27US FAERS
176PallorFAERS: 27US FAERS
177Partner stressFAERS: 27US FAERS
178Drug level below therapeuticFAERS: 26US FAERS
179Joint stiffnessFAERS: 26US FAERS
180No adverse eventFAERS: 26US FAERS
181Blood creatinine increasedFAERS: 25US FAERS
182Drug effect incompleteFAERS: 25US FAERS
183Hormone level abnormalFAERS: 25US FAERS
184InflammationFAERS: 25US FAERS
185Monocyte count increasedFAERS: 25US FAERS
186PneumoniaFAERS: 25US FAERS
187Thyroglobulin decreasedFAERS: 25US FAERS
188AgeusiaFAERS: 24US FAERS
189EpistaxisFAERS: 24US FAERS
190GastritisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Product taste abnormalFAERS: 24US FAERS
192SciaticaFAERS: 24US FAERS
193Tri-iodothyronine free increasedFAERS: 24US FAERS
194nervous system disorderFAERS: 24US FAERS
195Blood creatine phosphokinase increasedFAERS: 23US FAERS
196Impaired quality of lifeFAERS: 23US FAERS
197PsoriasisFAERS: 23US FAERS
198DysgraphiaFAERS: 22US FAERS
199FibromyalgiaFAERS: 22US FAERS
200InfluenzaFAERS: 22US FAERS
201Muscle tightnessFAERS: 22US FAERS
202SinusitisFAERS: 22US FAERS
203Irritable Bowel SyndromeFAERS: 21US FAERS
204Ocular discomfortFAERS: 21US FAERS
205Restless Legs SyndromeFAERS: 21US FAERS
206TrichorrhexisFAERS: 21US FAERS
207Autoimmune thyroiditisFAERS: 20US FAERS
208DeafnessFAERS: 20US FAERS
209Ear discomfortFAERS: 20US FAERS
210HyperchlorhydriaFAERS: 20US FAERS
211NeuralgiaFAERS: 20US FAERS
212Blood potassium increasedFAERS: 19US FAERS
213Cardiac discomfortFAERS: 19US FAERS
214DysuriaFAERS: 19US FAERS
215EpilepsyFAERS: 19US FAERS
216Frustration tolerance decreasedFAERS: 19US FAERS
217Hypertensive crisisFAERS: 19US FAERS
218Musculoskeletal chest painFAERS: 19US FAERS
219Personality ChangeFAERS: 19US FAERS
220AnhedoniaFAERS: 18US FAERS
221ArthritisFAERS: 18US FAERS
222Carpal Tunnel SyndromeFAERS: 18US FAERS
223Choking sensationFAERS: 18US FAERS
224LymphadenopathyFAERS: 18US FAERS
225Product physical issueFAERS: 18US FAERS
226Product shape issueFAERS: 18US FAERS
227Accidental drug intake by childFAERS: 17US FAERS
228BradyphreniaFAERS: 17US FAERS
229Gestational DiabetesFAERS: 17US FAERS
230High density lipoprotein increasedFAERS: 17US FAERS
231Intentional product misuseFAERS: 17US FAERS
232Lymphocyte count increasedFAERS: 17US FAERS
233OsteoporosisFAERS: 17US FAERS
234Pulmonary EmbolismFAERS: 17US FAERS
235WheezingFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
236AsthenopiaFAERS: 16US FAERS
237Breast FeedingFAERS: 16US FAERS
238ColitisFAERS: 16US FAERS
239Drug abuseFAERS: 16US FAERS
240HungerFAERS: 16US FAERS
241Migraine with AuraFAERS: 16US FAERS
242Pelvic PainFAERS: 16US FAERS
243PolyuriaFAERS: 16US FAERS
244Poor quality drug administeredFAERS: 16US FAERS
245Sinus TachycardiaFAERS: 16US FAERS
246ToothacheFAERS: 16US FAERS
247Accidental exposure to product by childFAERS: 15US FAERS
248AphoniaFAERS: 15US FAERS
249Euphoric moodFAERS: 15US FAERS
250Expired product administeredFAERS: 15US FAERS
251Inappropriate schedule of drug administrationFAERS: 15US FAERS
252Physical disabilityFAERS: 15US FAERS
253Rash erythematousFAERS: 15US FAERS
254RetchingFAERS: 15US FAERS
255Accidental overdoseFAERS: 14US FAERS
256Facial paralysisFAERS: 14US FAERS
257Food AllergyFAERS: 14US FAERS
258MetrorrhagiaFAERS: 14US FAERS
259ParanoiaFAERS: 14US FAERS
260Bipolar DisorderFAERS: 13US FAERS
261Cardiac ArrestFAERS: 13US FAERS
262Depressed Level of ConsciousnessFAERS: 13US FAERS
263DysarthriaFAERS: 13US FAERS
264Exposure during breast feedingFAERS: 13US FAERS
265Intellectual DisabilityFAERS: 13US FAERS
266Low birth weight babyFAERS: 13US FAERS
267Product measured potency issueFAERS: 13US FAERS
268Respiratory distressFAERS: 13US FAERS
269Urinary IncontinenceFAERS: 13US FAERS
270Vulvovaginal drynessFAERS: 13US FAERS
271Wrong drug administeredFAERS: 13US FAERS
272Bulimia NervosaFAERS: 12US FAERS
273Cardiac FlutterFAERS: 12US FAERS
274Lymphocyte count decreasedFAERS: 12US FAERS
275Morbid thoughtsFAERS: 12US FAERS
276Muscle strainFAERS: 12US FAERS
277Pain of skinFAERS: 12US FAERS
278Patient IsolationFAERS: 12US FAERS
279Quality of life decreasedFAERS: 12US FAERS
280Supraventricular tachycardiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Thyroglobulin increasedFAERS: 12US FAERS
282Thyroid hormones increasedFAERS: 12US FAERS
283White blood cell count decreasedFAERS: 12US FAERS
284Altered state of consciousnessFAERS: 11US FAERS
285Circumstance or information capable of leading to medication errorFAERS: 11US FAERS
286DisabilityFAERS: 11US FAERS
287Drug exposure during pregnancyFAERS: 11US FAERS
288Erectile dysfunctionFAERS: 11US FAERS
289Libido disorderFAERS: 11US FAERS
290Limb injuryFAERS: 11US FAERS
291NoduleFAERS: 11US FAERS
292Phobia of drivingFAERS: 11US FAERS
293ShockFAERS: 11US FAERS
294Temperature regulation disorderFAERS: 11US FAERS
295Therapy changeFAERS: 11US FAERS
296Total cholesterol/HDL ratio increasedFAERS: 11US FAERS
297CyanosisFAERS: 10US FAERS
298CystitisFAERS: 10US FAERS
299Drug level changedFAERS: 10US FAERS
300Drug prescribing errorFAERS: 10US FAERS
301General physical condition abnormalFAERS: 10US FAERS
302Illness anxiety disorderFAERS: 10US FAERS
303Inappropriate schedule of product administrationFAERS: 10US FAERS
304Intentional product use issueFAERS: 10US FAERS
305Muscle RigidityFAERS: 10US FAERS
306Neutrophil count decreasedFAERS: 10US FAERS
307OverweightFAERS: 10US FAERS
308Panic DisorderFAERS: 10US FAERS
309PeriarthritisFAERS: 10US FAERS
310Product solubility abnormalFAERS: 10US FAERS
311SneezingFAERS: 10US FAERS
312Alopecia AreataFAERS: 9US FAERS
313Ankle FractureFAERS: 9US FAERS
314Antisocial Personality DisorderFAERS: 9US FAERS
315Blood creatine increasedFAERS: 9US FAERS
316ChromaturiaFAERS: 9US FAERS
317Congenital HypothyroidismFAERS: 9US FAERS
318Fear-related avoidance of activitiesFAERS: 9US FAERS
319Grip strength decreasedFAERS: 9US FAERS
320HemiparesisFAERS: 9US FAERS
321HepatitisFAERS: 9US FAERS
322HypertrichosisFAERS: 9US FAERS
323InfectionFAERS: 9US FAERS
324Intestinal ObstructionFAERS: 9US FAERS
325MoroseFAERS: 9US FAERS
326Skin reactionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Thyroid NeoplasmFAERS: 9US FAERS
328Thyroxine free abnormalFAERS: 9US FAERS
329Urinary RetentionFAERS: 9US FAERS
330AbuliaFAERS: 8US FAERS
331Acute kidney injuryFAERS: 8US FAERS
332Allergic reaction to excipientFAERS: 8US FAERS
333AnosmiaFAERS: 8US FAERS
334Blood alkaline phosphatase increasedFAERS: 8US FAERS
335Blood parathyroid hormone increasedFAERS: 8US FAERS
336CataractFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Congenital hyperthyroidismFAERS: 8US FAERS
338Drug level fluctuatingFAERS: 8US FAERS
339Eye BurnsFAERS: 8US FAERS
340Gastric ulcerFAERS: 8US FAERS
341GastroenteritisFAERS: 8US FAERS
342GlossitisFAERS: 8US FAERS
343HyperventilationFAERS: 8US FAERS
344Lactose IntoleranceFAERS: 8US FAERS
345NocturiaFAERS: 8US FAERS
346Oropharyngeal discomfortFAERS: 8US FAERS
347PericarditisFAERS: 8US FAERS
348PharyngitisFAERS: 8US FAERS
349Pre-existing condition improvedFAERS: 8US FAERS
350Rheumatoid ArthritisFAERS: 8US FAERS
351Saliva alteredFAERS: 8US FAERS
352TachyarrhythmiaFAERS: 8US FAERS
353Walking aid userFAERS: 8US FAERS
354treatment failureFAERS: 8US FAERS
355AbasiaFAERS: 7US FAERS
356Blood 25-hydroxycholecalciferol decreasedFAERS: 7US FAERS
357Blood alkaline phosphatase decreasedFAERS: 7US FAERS
358Blood count abnormalFAERS: 7US FAERS
359Blood glucose decreasedFAERS: 7US FAERS
360CholelithiasisFAERS: 7US FAERS
361ClumsinessFAERS: 7US FAERS
362Coronary Artery DiseaseFAERS: 7US FAERS
363Creatinine renal clearance decreasedFAERS: 7US FAERS
364Decreased immune responsivenessFAERS: 7US FAERS
365Drug toxicityFAERS: 7US FAERS
366DysenteryFAERS: 7US FAERS
367EcchymosisFAERS: 7US FAERS
368Emotional povertyFAERS: 7US FAERS
369FractureFAERS: 7US FAERS
370GingivitisFAERS: 7US FAERS
371Gluten sensitivityFAERS: 7US FAERS
372Idiosyncratic drug reactionFAERS: 7US FAERS
373Incorrect product storageFAERS: 7US FAERS
374InfarctionFAERS: 7US FAERS
375Intentional drug misuseFAERS: 7US FAERS
376Intestinal transit time abnormalFAERS: 7US FAERS
377Joint injuryFAERS: 7US FAERS
378Lipase increasedFAERS: 7US FAERS
379Maternal exposure timing unspecifiedFAERS: 7US FAERS
380NeutropeniaFAERS: 7US FAERS
381PhlebitisFAERS: 7US FAERS
382Pre-EclampsiaFAERS: 7US FAERS
383Product counterfeitFAERS: 7US FAERS
384Product use issueFAERS: 7US FAERS
385Sjogren's SyndromeFAERS: 7US FAERS
386Somatic symptom disorderFAERS: 7US FAERS
387StomatitisFAERS: 7US FAERS
388Suspected counterfeit productFAERS: 7US FAERS
389Tension HeadacheFAERS: 7US FAERS
390Thermal burnFAERS: 7US FAERS
391Tongue discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
392Vitamin D DeficiencyFAERS: 7US FAERS
393Apparent deathFAERS: 6US FAERS
394Atrial FlutterFAERS: 6US FAERS
395BlepharospasmFAERS: 6US FAERS
396Blood prolactin increasedFAERS: 6US FAERS
397Blood sodium decreasedFAERS: 6US FAERS
398Body temperature fluctuationFAERS: 6US FAERS
399Bowel movement irregularityFAERS: 6US FAERS
400CholestasisFAERS: 6US FAERS
401ChoreoathetosisFAERS: 6US FAERS
402Cortisol increasedFAERS: 6US FAERS
403Dark circles under eyesFAERS: 6US FAERS
404DeliriumFAERS: 6US FAERS
405DermatitisFAERS: 6US FAERS
406DiplegiaFAERS: 6US FAERS
407EpicondylitisFAERS: 6US FAERS
408Gastric pH decreasedFAERS: 6US FAERS
409GlaucomaFAERS: 6US FAERS
410HerniaFAERS: 6US FAERS
411Hypothalamo-pituitary disorderFAERS: 6US FAERS
412Ligament painFAERS: 6US FAERS
413Monocyte count decreasedFAERS: 6US FAERS
414MonoplegiaFAERS: 6US FAERS
415Mouth swellingFAERS: 6US FAERS
416MyocarditisFAERS: 6US FAERS
417NephrolithiasisFAERS: 6US FAERS
418ObesityFAERS: 6US FAERS
419OsteopeniaFAERS: 6US FAERS
420PolydipsiaFAERS: 6US FAERS
421PolyhydramniosFAERS: 6US FAERS
422Product size issueFAERS: 6US FAERS
423Protein total decreasedFAERS: 6US FAERS
424ProteinuriaFAERS: 6US FAERS
425Pulmonary painFAERS: 6US FAERS
426Respiratory FailureFAERS: 6US FAERS
427Skin lesionFAERS: 6US FAERS
428SnoringFAERS: 6US FAERS
429Synovial CystFAERS: 6US FAERS
430Transaminases increasedFAERS: 6US FAERS
431Tri-iodothyronine abnormalFAERS: 6US FAERS
432jaundiceFAERS: 6US FAERS
433Acute myocardial infarctionFAERS: 5US FAERS
434Adjustment disorder with depressed moodFAERS: 5US FAERS
435AgoraphobiaFAERS: 5US FAERS
436Blood cholesterolFAERS: 5US FAERS
437Blood creatinine decreasedFAERS: 5US FAERS
438Blood potassium decreasedFAERS: 5US FAERS
439Blood urea increasedFAERS: 5US FAERS
440Bone density decreasedFAERS: 5US FAERS
441Breast tendernessFAERS: 5US FAERS
442Cerebral disorderFAERS: 5US FAERS
443ConjunctivitisFAERS: 5US FAERS
444Depression suicidalFAERS: 5US FAERS
445Disease ProgressionFAERS: 5US FAERS
446Disease recurrenceFAERS: 5US FAERS
447Drug administration errorFAERS: 5US FAERS
448Ear congestionFAERS: 5US FAERS
449Economic problemFAERS: 5US FAERS
450Expired drug administeredFAERS: 5US FAERS
451Extra dose administeredFAERS: 5US FAERS
452Feelings of worthlessnessFAERS: 5US FAERS
453Fibrin D dimer increasedFAERS: 5US FAERS
454Food cravingFAERS: 5US FAERS
455Heat StrokeFAERS: 5US FAERS
456HemiplegiaFAERS: 5US FAERS
457HepatomegalyFAERS: 5US FAERS
458HyperphagiaFAERS: 5US FAERS
459HyporeflexiaFAERS: 5US FAERS
460HypoxiaFAERS: 5US FAERS
461ImmobileFAERS: 5US FAERS
462Inappropriate affectFAERS: 5US FAERS
463IncoherentFAERS: 5US FAERS
464InfertilityFAERS: 5US FAERS
465Intercepted drug dispensing errorFAERS: 5US FAERS
466Iron deficiencyFAERS: 5US FAERS
467Maternal exposure before pregnancyFAERS: 5US FAERS
468Mental status changesFAERS: 5US FAERS
469Nerve injuryFAERS: 5US FAERS
470Oral painFAERS: 5US FAERS
471Performance status decreasedFAERS: 5US FAERS
472Persistent depressive disorderFAERS: 5US FAERS
473PolyarthritisFAERS: 5US FAERS
474Product dose omissionFAERS: 5US FAERS
475Product packaging issueFAERS: 5US FAERS
476Productive CoughFAERS: 5US FAERS
477Pulmonary HypertensionFAERS: 5US FAERS
478PyelonephritisFAERS: 5US FAERS
479RosaceaFAERS: 5US FAERS
480ScabFAERS: 5US FAERS
481Skin irritationFAERS: 5US FAERS
482Slow response to stimuliFAERS: 5US FAERS
483Status EpilepticusFAERS: 5US FAERS
484Sudden onset of sleepFAERS: 5US FAERS
485TetanyFAERS: 5US FAERS
486Therapeutic product effect decreasedFAERS: 5US FAERS
487ThrombosisFAERS: 5US FAERS
488ThyroiditisFAERS: 5US FAERS
489TrismusFAERS: 5US FAERS
490Vulvovaginal burning sensationFAERS: 5US FAERS
491Vulvovaginal mycotic infectionFAERS: 5US FAERS
492Wrong technique in drug usage processFAERS: 5US FAERS
493Adnexa uteri painFAERS: 4US FAERS
494Anaphylactic shockFAERS: 4US FAERS
495Anembryonic gestationFAERS: 4US FAERS
496Anorectal discomfortFAERS: 4US FAERS
497AnorexiaFAERS: 4US FAERS
498Antibody test abnormalFAERS: 4US FAERS
499Apallic syndromeFAERS: 4US FAERS
500Bed restFAERS: 4US FAERS
501Bilirubin conjugated increasedFAERS: 4US FAERS
502Blood iron decreasedFAERS: 4US FAERS
503Blood phosphorus decreasedFAERS: 4US FAERS
504Blood triglycerides abnormalFAERS: 4US FAERS
505BradykinesiaFAERS: 4US FAERS
506BruxismFAERS: 4US FAERS
507CellulitisFAERS: 4US FAERS
508ClaustrophobiaFAERS: 4US FAERS
509Completed SuicideFAERS: 4US FAERS
510Conversion disorderFAERS: 4US FAERS
511Cytomegalovirus test positiveFAERS: 4US FAERS
512Deep Vein ThrombosisFAERS: 4US FAERS
513Drug effect delayedFAERS: 4US FAERS
514Drug level increasedFAERS: 4US FAERS
515Drug resistanceFAERS: 4US FAERS
516DyspareuniaFAERS: 4US FAERS
517EndometriosisFAERS: 4US FAERS
518EnuresisFAERS: 4US FAERS
519ErysipelasFAERS: 4US FAERS
520Flank PainFAERS: 4US FAERS
521Foreign body sensation in eyesFAERS: 4US FAERS
522Gamma-glutamyltransferase decreasedFAERS: 4US FAERS
523Gene MutationFAERS: 4US FAERS
524Growth retardationFAERS: 4US FAERS
525HypohidrosisFAERS: 4US FAERS
526HypophagiaFAERS: 4US FAERS
527Impaired self-careFAERS: 4US FAERS
528Intercepted medication errorFAERS: 4US FAERS
529Labile blood pressureFAERS: 4US FAERS
530Mastication disorderFAERS: 4US FAERS
531Maternal exposure during deliveryFAERS: 4US FAERS
532Medication residueFAERS: 4US FAERS
533Mineral deficiencyFAERS: 4US FAERS
534MyopiaFAERS: 4US FAERS
535Neonatal disorderFAERS: 4US FAERS
536Neonatal thyrotoxicosisFAERS: 4US FAERS
537Noninfective gingivitisFAERS: 4US FAERS
538Nonspecific reactionFAERS: 4US FAERS
539OligohydramniosFAERS: 4US FAERS
540Oral fungal infectionFAERS: 4US FAERS
541Pericardial effusionFAERS: 4US FAERS
542PoisoningFAERS: 4US FAERS
543Post procedural complicationFAERS: 4US FAERS
544PregnancyFAERS: 4US FAERS
545Product use complaintFAERS: 4US FAERS
546Pulmonary FibrosisFAERS: 4US FAERS
547RegurgitationFAERS: 4US FAERS
548RhabdomyolysisFAERS: 4US FAERS
549RhinitisFAERS: 4US FAERS
550Sexual DysfunctionFAERS: 4US FAERS
551Sexual inhibitionFAERS: 4US FAERS
552Skin WrinklingFAERS: 4US FAERS
553SomnambulismFAERS: 4US FAERS
554Stevens-Johnson SyndromeFAERS: 4US FAERS
555StrabismusFAERS: 4US FAERS
556Stress at workFAERS: 4US FAERS
557TachyphreniaFAERS: 4US FAERS
558ThrombocytopeniaFAERS: 4US FAERS
559ThrombophlebitisFAERS: 4US FAERS
560Thyroid atrophyFAERS: 4US FAERS
561Thyroid hormones decreasedFAERS: 4US FAERS
562Time perception alteredFAERS: 4US FAERS
563Transferrin saturation increasedFAERS: 4US FAERS
564Tri-iodothyronine free abnormalFAERS: 4US FAERS
565Vaginal DischargeFAERS: 4US FAERS
566VasculitisFAERS: 4US FAERS
567Violence-related symptomFAERS: 4US FAERS
568Vitreous DetachmentFAERS: 4US FAERS
569YawningFAERS: 4US FAERS
570Abdominal massFAERS: 3US FAERS
571Abortion earlyFAERS: 3US FAERS
572Anal FissureFAERS: 3US FAERS
573AscitesFAERS: 3US FAERS
574Atrioventricular BlockFAERS: 3US FAERS
575AversionFAERS: 3US FAERS
576Biliary ColicFAERS: 3US FAERS
577Blood chloride decreasedFAERS: 3US FAERS
578Blood cholesterol abnormalFAERS: 3US FAERS
579Blood glucose fluctuationFAERS: 3US FAERS
580Blood lactate dehydrogenase increasedFAERS: 3US FAERS
581Blood parathyroid hormone decreasedFAERS: 3US FAERS
582Blood phosphorus increasedFAERS: 3US FAERS
583Blood sodium increasedFAERS: 3US FAERS
584Blood uric acid decreasedFAERS: 3US FAERS
585Blood urine presentFAERS: 3US FAERS
586Bronchial ObstructionFAERS: 3US FAERS
587BronchitisFAERS: 3US FAERS
588CachexiaFAERS: 3US FAERS
589CardiomegalyFAERS: 3US FAERS
590Carotid pulse abnormalFAERS: 3US FAERS
591Cervicobrachial syndromeFAERS: 3US FAERS
592Coagulation factor IX level increasedFAERS: 3US FAERS
593Coagulation factor VIII level increasedFAERS: 3US FAERS
594Coagulation factor X level increasedFAERS: 3US FAERS
595DementiaFAERS: 3US FAERS
596Dermatitis acneiformFAERS: 3US FAERS
597Diabetes InsipidusFAERS: 3US FAERS
598Drug exposure via breast milkFAERS: 3US FAERS
599DysphemiaFAERS: 3US FAERS
600DystoniaFAERS: 3US FAERS
601Electrocardiogram abnormalFAERS: 3US FAERS
602EosinophiliaFAERS: 3US FAERS
603Exposure via fatherFAERS: 3US FAERS
604Eyelid Function DisorderFAERS: 3US FAERS
605Facial NeuralgiaFAERS: 3US FAERS
606Facial PainFAERS: 3US FAERS
607FasciitisFAERS: 3US FAERS
608Foreign body in respiratory tractFAERS: 3US FAERS
609Foreign body traumaFAERS: 3US FAERS
610Gastric DilatationFAERS: 3US FAERS
611Gastrointestinal carcinomaFAERS: 3US FAERS
612HirsutismFAERS: 3US FAERS
613HypercapniaFAERS: 3US FAERS
614HyperreflexiaFAERS: 3US FAERS
615HypomaniaFAERS: 3US FAERS
616HypometabolismFAERS: 3US FAERS
617IncontinenceFAERS: 3US FAERS
618Incorrect drug dosage form administeredFAERS: 3US FAERS
619Increased tendency to bruiseFAERS: 3US FAERS
620Increased upper airway secretionFAERS: 3US FAERS
621Intentional self-injuryFAERS: 3US FAERS
622Investigation abnormalFAERS: 3US FAERS
623LazinessFAERS: 3US FAERS
624LeukopeniaFAERS: 3US FAERS
625Lichen PlanusFAERS: 3US FAERS
626Living AloneFAERS: 3US FAERS
627MenopauseFAERS: 3US FAERS
628Metabolic acidosisFAERS: 3US FAERS
629Milk AllergyFAERS: 3US FAERS
630Multiple SclerosisFAERS: 3US FAERS
631MydriasisFAERS: 3US FAERS
632NarcolepsyFAERS: 3US FAERS
633Neonatal tachycardiaFAERS: 3US FAERS
634Ocular RosaceaFAERS: 3US FAERS
635Oral pruritusFAERS: 3US FAERS
636Oropharyngeal swellingFAERS: 3US FAERS
637OsteitisFAERS: 3US FAERS
638Plasminogen activator inhibitor increasedFAERS: 3US FAERS
639Prescribed overdoseFAERS: 3US FAERS
640Product blister packaging issueFAERS: 3US FAERS
641Product complaintFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
642Product dispensing errorFAERS: 3US FAERS
643Product packaging confusionFAERS: 3US FAERS
644Product storage errorFAERS: 3US FAERS
645Product use in unapproved indicationFAERS: 3US FAERS
646Psychomotor skills impairedFAERS: 3US FAERS
647Renal ColicFAERS: 3US FAERS
648Respiratory arrestFAERS: 3US FAERS
649Respiratory tract congestionFAERS: 3US FAERS
650Rheumatic disorderFAERS: 3US FAERS
651Rotator cuff syndromeFAERS: 3US FAERS
652SarcoidosisFAERS: 3US FAERS
653ScreamingFAERS: 3US FAERS
654Secretion dischargeFAERS: 3US FAERS
655SepsisFAERS: 3US FAERS
656Skin discomfortFAERS: 3US FAERS
657StillbirthFAERS: 3US FAERS
658SubileusFAERS: 3US FAERS
659Suppressed lactationFAERS: 3US FAERS
660Tablet physical issueFAERS: 3US FAERS
661Tendon discomfortFAERS: 3US FAERS
662Therapy cessationFAERS: 3US FAERS
663ThermophobiaFAERS: 3US FAERS
664Ultrasound antenatal screenFAERS: 3US FAERS
665Uterine CancerFAERS: 3US FAERS
666Vestibular NeuronitisFAERS: 3US FAERS
667Von Willebrand's factor activity increasedFAERS: 3US FAERS
668Von Willebrand's factor antigen increasedFAERS: 3US FAERS
669XerosisFAERS: 3US FAERS
670AbscessFAERS: 2US FAERS
671Accidental exposure to productFAERS: 2US FAERS
672AcidosisFAERS: 2US FAERS
673Acute psychosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
674Allergy to chemicalsFAERS: 2US FAERS
675Alpha 2 globulin increasedFAERS: 2US FAERS
676Amniotic fluid volume decreasedFAERS: 2US FAERS
677AneurysmFAERS: 2US FAERS
678Anti-transglutaminase antibody increasedFAERS: 2US FAERS
679Aspartate aminotransferase decreasedFAERS: 2US FAERS
680AtaxiaFAERS: 2US FAERS
681AutophobiaFAERS: 2US FAERS
682Back disorderFAERS: 2US FAERS
683Biochemical pregnancyFAERS: 2US FAERS
684Bipolar I disorderFAERS: 2US FAERS
685Blood 1,25-dihydroxycholecalciferol decreasedFAERS: 2US FAERS
686Blood albumin decreasedFAERS: 2US FAERS
687Blood bicarbonate abnormalFAERS: 2US FAERS
688Blood glucose abnormalFAERS: 2US FAERS
689Blood immunoglobulin A increasedFAERS: 2US FAERS
690Blood insulin abnormalFAERS: 2US FAERS
691Blood iron increasedFAERS: 2US FAERS
692Blood magnesium decreasedFAERS: 2US FAERS
693Blood magnesium increasedFAERS: 2US FAERS
694Blood prolactin decreasedFAERS: 2US FAERS
695Blood thrombin increasedFAERS: 2US FAERS
696Bone density abnormalFAERS: 2US FAERS
697BoredomFAERS: 2US FAERS
698Breast discomfortFAERS: 2US FAERS
699Breech PresentationFAERS: 2US FAERS
700Bronchial HyperreactivityFAERS: 2US FAERS
701Burning Mouth SyndromeFAERS: 2US FAERS
702C-reactive protein abnormalFAERS: 2US FAERS
703Carcinoembryonic antigen increasedFAERS: 2US FAERS
704Cardiac dysfunctionFAERS: 2US FAERS
705Cardiac enzymes increasedFAERS: 2US FAERS
706Cardiovascular insufficiencyFAERS: 2US FAERS
707Cell DeathFAERS: 2US FAERS
708CheilitisFAERS: 2US FAERS
709Cleft PalateFAERS: 2US FAERS
710Corrective lens userFAERS: 2US FAERS
711Cortisol decreasedFAERS: 2US FAERS
712Counterfeit drug administeredFAERS: 2US FAERS
713Creatinine urine decreasedFAERS: 2US FAERS
714Cronkhite-Canada SyndromeFAERS: 2US FAERS
715CystFAERS: 2US FAERS
716Dehydroepiandrosterone increasedFAERS: 2US FAERS
717Dengue FeverFAERS: 2US FAERS
718Dependent Personality DisorderFAERS: 2US FAERS
719Device looseningFAERS: 2US FAERS
720Disseminated Intravascular CoagulationFAERS: 2US FAERS
721DissociationFAERS: 2US FAERS
722DiverticulitisFAERS: 2US FAERS
723Drug ineffective for unapproved indicationFAERS: 2US FAERS
724DyscheziaFAERS: 2US FAERS
725DyslexiaFAERS: 2US FAERS
726Ectopic PregnancyFAERS: 2US FAERS
727Ejection Fraction DecreasedFAERS: 2US FAERS
728EmbolismFAERS: 2US FAERS
729Endometrial HyperplasiaFAERS: 2US FAERS
730Erythema NodosumFAERS: 2US FAERS
731Essential HypertensionFAERS: 2US FAERS
732Extraocular Muscle ParesisFAERS: 2US FAERS
733Eye InfectionFAERS: 2US FAERS
734Eye inflammationFAERS: 2US FAERS
735Eyelid skin drynessFAERS: 2US FAERS
736Eyelids pruritusFAERS: 2US FAERS
737Facial asymmetryFAERS: 2US FAERS
738Flat affectFAERS: 2US FAERS
739Foaming at mouthFAERS: 2US FAERS
740Food PoisoningFAERS: 2US FAERS
741FrustrationFAERS: 2US FAERS
742GangreneFAERS: 2US FAERS
743Gastrointestinal hypomotilityFAERS: 2US FAERS
744Gastrointestinal sounds abnormalFAERS: 2US FAERS
745Genital HerpesFAERS: 2US FAERS
746GlycosuriaFAERS: 2US FAERS
747GoutFAERS: 2US FAERS
748Guillain-Barre SyndromeFAERS: 2US FAERS
749Hair growth rate abnormalFAERS: 2US FAERS
750Hair injuryFAERS: 2US FAERS
751Hallucinations, mixedFAERS: 2US FAERS
752HemiparaesthesiaFAERS: 2US FAERS
753Hepatic calcificationFAERS: 2US FAERS
754Hepatitis A antibody positiveFAERS: 2US FAERS
755HepatotoxicityFAERS: 2US FAERS
756HostilityFAERS: 2US FAERS
757HydronephrosisFAERS: 2US FAERS
758HypertransaminasaemiaFAERS: 2US FAERS
759HypogonadismFAERS: 2US FAERS
760HypopituitarismFAERS: 2US FAERS
761Hyporesponsive to stimuliFAERS: 2US FAERS
762Incorrect route of drug administrationFAERS: 2US FAERS
763Increased viscosity of upper respiratory secretionFAERS: 2US FAERS
764Infectious MononucleosisFAERS: 2US FAERS
765Inflammatory painFAERS: 2US FAERS
766Injection site bruisingFAERS: 2US FAERS
767Injection site erythemaFAERS: 2US FAERS
768Injection site massFAERS: 2US FAERS
769Insurance issueFAERS: 2US FAERS
770Intercepted drug administration errorFAERS: 2US FAERS
771Irregular sleep phaseFAERS: 2US FAERS
772Joint Range of Motion DecreasedFAERS: 2US FAERS
773Laryngeal discomfortFAERS: 2US FAERS
774Lateral Medullary SyndromeFAERS: 2US FAERS
775Magnesium DeficiencyFAERS: 2US FAERS
776Maternal exposure during breast feedingFAERS: 2US FAERS
777Medication residue presentFAERS: 2US FAERS
778MeningiomaFAERS: 2US FAERS
779MetamorphopsiaFAERS: 2US FAERS
780Micturition frequency decreasedFAERS: 2US FAERS
781MisophoniaFAERS: 2US FAERS
782MoaningFAERS: 2US FAERS
783Multiple Chemical SensitivityFAERS: 2US FAERS
784Multiple allergiesFAERS: 2US FAERS
785Multiple sclerosis relapseFAERS: 2US FAERS
786Muscle SpasticityFAERS: 2US FAERS
787MutismFAERS: 2US FAERS
788Myasthenia GravisFAERS: 2US FAERS
789MyoclonusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
790MyositisFAERS: 2US FAERS
791Nasal discomfortFAERS: 2US FAERS
792Neonatal aspirationFAERS: 2US FAERS
793Neonatal intestinal dilatationFAERS: 2US FAERS
794NystagmusFAERS: 2US FAERS
795Obsessive thoughtsFAERS: 2US FAERS
796Ocular vascular disorderFAERS: 2US FAERS
797Oral candidiasisFAERS: 2US FAERS
798Oral infectionFAERS: 2US FAERS
799Paranoid Personality DisorderFAERS: 2US FAERS
800Patent ductus arteriosusFAERS: 2US FAERS
801Pathogen resistanceFAERS: 2US FAERS
802PeriodontitisFAERS: 2US FAERS
803Peripheral venous diseaseFAERS: 2US FAERS
804PeriphlebitisFAERS: 2US FAERS
805PeritonitisFAERS: 2US FAERS
806Pharyngolaryngeal PainFAERS: 2US FAERS
807PhonophobiaFAERS: 2US FAERS
808Physical product label issueFAERS: 2US FAERS
809Polymyalgia RheumaticaFAERS: 2US FAERS
810Poor personal hygieneFAERS: 2US FAERS
811Poor weight gain neonatalFAERS: 2US FAERS
812Premenstrual syndromeFAERS: 2US FAERS
813Product administration errorFAERS: 2US FAERS
814Product appearance confusionFAERS: 2US FAERS
815Product comminglingFAERS: 2US FAERS
816Product difficult to swallowFAERS: 2US FAERS
817Product label issueFAERS: 2US FAERS
818Product lot number issueFAERS: 2US FAERS
819Product prescribing errorFAERS: 2US FAERS
820Product tamperingFAERS: 2US FAERS
821Protein total increasedFAERS: 2US FAERS
822Protein-losing gastroenteropathyFAERS: 2US FAERS
823PseudostrokeFAERS: 2US FAERS
824Psychiatric decompensationFAERS: 2US FAERS
825Pubic painFAERS: 2US FAERS
826Pulmonary congestionFAERS: 2US FAERS
827QuadriplegiaFAERS: 2US FAERS
828RalesFAERS: 2US FAERS
829Reaction to azo-dyesFAERS: 2US FAERS
830Rectal tenesmusFAERS: 2US FAERS
831Reverse tri-iodothyronine increasedFAERS: 2US FAERS
832SchizophreniaFAERS: 2US FAERS
833Secondary hyperthyroidismFAERS: 2US FAERS
834Senile dementiaFAERS: 2US FAERS
835Septic ShockFAERS: 2US FAERS
836Sinus bradycardiaFAERS: 2US FAERS
837SoporFAERS: 2US FAERS
838Spinal column injuryFAERS: 2US FAERS
839Spinal column stenosisFAERS: 2US FAERS
840StuporFAERS: 2US FAERS
841Sudden deathFAERS: 2US FAERS
842SynovitisFAERS: 2US FAERS
843Therapeutic product effect increasedFAERS: 2US FAERS
844Therapeutic response changedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
845Throat cancerFAERS: 2US FAERS
846ThrombocytosisFAERS: 2US FAERS
847Thyroglossal CystFAERS: 2US FAERS
848Thyroid stimulating immunoglobulin increasedFAERS: 2US FAERS
849ThyroidectomyFAERS: 2US FAERS
850Thyrotoxic periodic paralysisFAERS: 2US FAERS
851TonsillitisFAERS: 2US FAERS
852Tooth ErosionFAERS: 2US FAERS
853TorticollisFAERS: 2US FAERS
854Total cholesterol/HDL ratio decreasedFAERS: 2US FAERS
855Transcription medication errorFAERS: 2US FAERS
856Transient psychosisFAERS: 2US FAERS
857Trisomy 21FAERS: 2US FAERS
858UlcerFAERS: 2US FAERS
859Upper-airway cough syndromeFAERS: 2US FAERS
860Urinary hesitationFAERS: 2US FAERS
861Urinary tract discomfortFAERS: 2US FAERS
862Urine flow decreasedFAERS: 2US FAERS
863Uterine PolypFAERS: 2US FAERS
864Vaginal ProlapseFAERS: 2US FAERS
865Vascular painFAERS: 2US FAERS
866VasospasmFAERS: 2US FAERS
867Venous ThrombosisFAERS: 2US FAERS
868Ventricular FibrillationFAERS: 2US FAERS
869Visual brightnessFAERS: 2US FAERS
870Vitamin D abnormalFAERS: 2US FAERS
871VitiligoFAERS: 2US FAERS
872Vitreous floatersFAERS: 2US FAERS
873Vocal Cord ParalysisFAERS: 2US FAERS
874Vulvovaginal discomfortFAERS: 2US FAERS
875Wrong doseFAERS: 2US FAERS
876XerophthalmiaFAERS: 2US FAERS
877furuncleFAERS: 2US FAERS
878muscle injuryFAERS: 2US FAERS
879ABO incompatibilityFAERS: 1US FAERS
880Abdominal rigidityFAERS: 1US FAERS
881Accidental exposureFAERS: 1US FAERS
882Acoustic NeuromaFAERS: 1US FAERS
883Acral overgrowthFAERS: 1US FAERS
884Action TremorFAERS: 1US FAERS
885Acute prerenal failureFAERS: 1US FAERS
886Adjusted calcium decreasedFAERS: 1US FAERS
887Adjustment disorder with mixed anxiety and depressed moodFAERS: 1US FAERS
888Agitated depressionFAERS: 1US FAERS
889AgranulocytosisFAERS: 1US FAERS
890AgraphiaFAERS: 1US FAERS
891Alcohol IntoleranceFAERS: 1US FAERS
892Alcohol abuseFAERS: 1US FAERS
893Allergic respiratory symptomFAERS: 1US FAERS
894Allergic sinusitisFAERS: 1US FAERS
895Alopecia totalisFAERS: 1US FAERS
896Alopecia universalisFAERS: 1US FAERS
897AmaurosisFAERS: 1US FAERS
898Amniotic fluid volume increasedFAERS: 1US FAERS
899AmyloidosisFAERS: 1US FAERS
900Anal fungal infectionFAERS: 1US FAERS
901Anal sphincter atonyFAERS: 1US FAERS
902Anaphylactoid ReactionFAERS: 1US FAERS
903AniridiaFAERS: 1US FAERS
904AnisocytosisFAERS: 1US FAERS
905Ankylosing spondylitisFAERS: 1US FAERS
906Anorexia NervosaFAERS: 1US FAERS
907AnorgasmiaFAERS: 1US FAERS
908Anti-aquaporin-4 antibodyFAERS: 1US FAERS
909Anti-thyroid antibody negativeFAERS: 1US FAERS
910Anti-transglutaminase antibodyFAERS: 1US FAERS
911Antibody test positiveFAERS: 1US FAERS
912Antigliadin antibody positiveFAERS: 1US FAERS
913Antiphospholipid SyndromeFAERS: 1US FAERS
914AnuriaFAERS: 1US FAERS
915Aortic AneurysmFAERS: 1US FAERS
916Apolipoprotein A-I decreasedFAERS: 1US FAERS
917Apolipoprotein B increasedFAERS: 1US FAERS
918AppendicitisFAERS: 1US FAERS
919Arterial thrombosisFAERS: 1US FAERS
920ArteritisFAERS: 1US FAERS
921ArthrodesisFAERS: 1US FAERS
922AtelectasisFAERS: 1US FAERS
923AtopyFAERS: 1US FAERS
924AuraFAERS: 1US FAERS
925Automatic bladderFAERS: 1US FAERS
926Autonomic nervous system imbalanceFAERS: 1US FAERS
927Avoidant Personality DisorderFAERS: 1US FAERS
928Bacterial VaginosisFAERS: 1US FAERS
929Basal cell carcinomaFAERS: 1US FAERS
930BelligerenceFAERS: 1US FAERS
931Benign NeoplasmFAERS: 1US FAERS
932Benign neoplasm of thyroid glandFAERS: 1US FAERS
933Beta 2 microglobulin increasedFAERS: 1US FAERS
934Bladder discomfortFAERS: 1US FAERS
935Bladder neck sclerosisFAERS: 1US FAERS
936Bladder painFAERS: 1US FAERS
937BlepharochalasisFAERS: 1US FAERS
938Blood 25-hydroxycholecalciferol increasedFAERS: 1US FAERS
939Blood albumin abnormalFAERS: 1US FAERS
940Blood albumin increasedFAERS: 1US FAERS
941Blood alkaline phosphataseFAERS: 1US FAERS
942Blood bilirubin unconjugated increasedFAERS: 1US FAERS
943Blood chloride abnormalFAERS: 1US FAERS
944Blood chloride increasedFAERS: 1US FAERS
945Blood cortisol decreasedFAERS: 1US FAERS
946Blood cortisol increasedFAERS: 1US FAERS
947Blood creatine phosphokinaseFAERS: 1US FAERS
948Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
949Blood creatine phosphokinase abnormalFAERS: 1US FAERS
950Blood creatinine abnormalFAERS: 1US FAERS
951Blood fibrinogen increasedFAERS: 1US FAERS
952Blood folate abnormalFAERS: 1US FAERS
953Blood folate decreasedFAERS: 1US FAERS
954Blood immunoglobulin E abnormalFAERS: 1US FAERS
955Blood immunoglobulin E increasedFAERS: 1US FAERS
956Blood pressure inadequately controlledFAERS: 1US FAERS
957Blood testosterone decreasedFAERS: 1US FAERS
958Body TemperatureFAERS: 1US FAERS
959Bone decalcificationFAERS: 1US FAERS
960Brain natriuretic peptide increasedFAERS: 1US FAERS
961Breast CystFAERS: 1US FAERS
962BronchiectasisFAERS: 1US FAERS
963BronchopneumopathyFAERS: 1US FAERS
964BursitisFAERS: 1US FAERS
965Calcium deficiencyFAERS: 1US FAERS
966Campylobacter infectionFAERS: 1US FAERS
967Cardiac neoplasm unspecifiedFAERS: 1US FAERS
968Cardiac ventricular disorderFAERS: 1US FAERS
969CarditisFAERS: 1US FAERS
970Carotid artery aneurysmFAERS: 1US FAERS
971Cavernous Sinus ThrombosisFAERS: 1US FAERS
972Cerebellar strokeFAERS: 1US FAERS
973Cerebral InfarctionFAERS: 1US FAERS
974Cervix carcinomaFAERS: 1US FAERS
975CholangitisFAERS: 1US FAERS
976Cholecystitis infectiveFAERS: 1US FAERS
977CholecystitisFAERS: 1US FAERS
978Cholestasis of pregnancyFAERS: 1US FAERS
979Chronic gastritisFAERS: 1US FAERS
980Chronic sinusitisFAERS: 1US FAERS
981Chronic throat clearingFAERS: 1US FAERS
982Claudication of jaw musclesFAERS: 1US FAERS
983Cluster HeadacheFAERS: 1US FAERS
984Coating in mouthFAERS: 1US FAERS
985Complicated fractureFAERS: 1US FAERS
986Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
987Concomitant disease aggravatedFAERS: 1US FAERS
988Congenital HydrocephalusFAERS: 1US FAERS
989Congenital cystic lungFAERS: 1US FAERS
990Congenital teratomaFAERS: 1US FAERS
991Conjunctival irritationFAERS: 1US FAERS
992Contraindicated product administeredFAERS: 1US FAERS
993CraniosynostosisFAERS: 1US FAERS
994Crystal urine presentFAERS: 1US FAERS
995Cutis LaxaFAERS: 1US FAERS
996DacryocystitisFAERS: 1US FAERS
997Dacryostenosis congenitalFAERS: 1US FAERS
998Deafness NeurosensoryFAERS: 1US FAERS
999Decreased eye contactFAERS: 1US FAERS
1000DeformityFAERS: 1US FAERS
1001Dental cariesFAERS: 1US FAERS
1002Dental cystFAERS: 1US FAERS
1003DependenceFAERS: 1US FAERS
1004Depressive delusionFAERS: 1US FAERS
1005Dermatitis HerpetiformisFAERS: 1US FAERS
1006Device deposit issueFAERS: 1US FAERS
1007Device material issueFAERS: 1US FAERS
1008Diabetic FootFAERS: 1US FAERS
1009Diabetic foetopathyFAERS: 1US FAERS
1010Diaphragmatic HerniaFAERS: 1US FAERS
1011Disease complicationFAERS: 1US FAERS
1012Disease susceptibilityFAERS: 1US FAERS
1013Documented hypersensitivity to administered drugFAERS: 1US FAERS
1014Drug DependenceFAERS: 1US FAERS
1015Drug effect variableFAERS: 1US FAERS
1016Drug name confusionFAERS: 1US FAERS
1017Drug screen negativeFAERS: 1US FAERS
1018Drug titration errorFAERS: 1US FAERS
1019Drug withdrawal convulsionsFAERS: 1US FAERS
1020Drug withdrawal syndromeFAERS: 1US FAERS
1021DuodenitisFAERS: 1US FAERS
1022DysmorphismFAERS: 1US FAERS
1023Ear canal injuryFAERS: 1US FAERS
1024Educational problemFAERS: 1US FAERS
1025Electrocardiogram J wave abnormalFAERS: 1US FAERS
1026Electrocardiogram ST segment abnormalFAERS: 1US FAERS
1027Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
1028Electroencephalogram abnormalFAERS: 1US FAERS
1029Elevated moodFAERS: 1US FAERS
1030EncephalomyelitisFAERS: 1US FAERS
1031Endolymphatic HydropsFAERS: 1US FAERS
1032Endometrial hypertrophyFAERS: 1US FAERS
1033Endotracheal intubation complicationFAERS: 1US FAERS
1034Enlarged uvulaFAERS: 1US FAERS
1035EnterocolitisFAERS: 1US FAERS
1036EnthesopathyFAERS: 1US FAERS
1037Epigastric discomfortFAERS: 1US FAERS
1038Epstein-Barr virus antibody positiveFAERS: 1US FAERS
1039Erythema MultiformeFAERS: 1US FAERS
1040Escherichia test positiveFAERS: 1US FAERS
1041Escherichia urinary tract infectionFAERS: 1US FAERS
1042Excessive eye blinkingFAERS: 1US FAERS
1043ExcoriationFAERS: 1US FAERS
1044Expiratory reserve volume decreasedFAERS: 1US FAERS
1045Exposure via bloodFAERS: 1US FAERS
1046Exposure via breast milkFAERS: 1US FAERS
1047Exposure via skin contactFAERS: 1US FAERS
1048Eye allergyFAERS: 1US FAERS
1049Eyelid painFAERS: 1US FAERS
1050Fallopian tube obstructionFAERS: 1US FAERS
1051Fear of weight gainFAERS: 1US FAERS
1052Feeding disorder neonatalFAERS: 1US FAERS
1053Fibroadenoma of breastFAERS: 1US FAERS
1054Finger hypoplasiaFAERS: 1US FAERS
1055Flight of ideasFAERS: 1US FAERS
1056Fontanelle depressedFAERS: 1US FAERS
1057FumblingFAERS: 1US FAERS
1058Gastrointestinal disorder congenitalFAERS: 1US FAERS
1059Gastrointestinal hypermotilityFAERS: 1US FAERS
1060Gastrointestinal infectionFAERS: 1US FAERS
1061Gastrointestinal inflammationFAERS: 1US FAERS
1062Gaze palsyFAERS: 1US FAERS
1063General symptomFAERS: 1US FAERS
1064Genital infectionFAERS: 1US FAERS
1065Genital tract inflammationFAERS: 1US FAERS
1066Gingival blisterFAERS: 1US FAERS
1067Gingival erythemaFAERS: 1US FAERS
1068Glomerular Filtration RateFAERS: 1US FAERS
1069Granuloma AnnulareFAERS: 1US FAERS
1070Guttate psoriasisFAERS: 1US FAERS
1071Hand prosthesis userFAERS: 1US FAERS
1072Head circumference abnormalFAERS: 1US FAERS
1073Head titubationFAERS: 1US FAERS
1074Heart SoundsFAERS: 1US FAERS
1075Heat ExhaustionFAERS: 1US FAERS
1076Helicobacter test positiveFAERS: 1US FAERS
1077Hepatic InfectionFAERS: 1US FAERS
1078Hepatic necrosisFAERS: 1US FAERS
1079Hepatitis A virus test positiveFAERS: 1US FAERS
1080Hepatitis B core antibody positiveFAERS: 1US FAERS
1081Hepatitis BFAERS: 1US FAERS
1082Hepatitis EFAERS: 1US FAERS
1083HepatosplenomegalyFAERS: 1US FAERS
1084Hernial eventrationFAERS: 1US FAERS
1085Herpes simplex test positiveFAERS: 1US FAERS
1086HidradenitisFAERS: 1US FAERS
1087Histrionic Personality DisorderFAERS: 1US FAERS
1088House dust allergyFAERS: 1US FAERS
1089Human chorionic gonadotropin decreasedFAERS: 1US FAERS
1090HyperaldosteronismFAERS: 1US FAERS
1091HyperkeratosisFAERS: 1US FAERS
1092HyperkinesiaFAERS: 1US FAERS
1093HyperlipasaemiaFAERS: 1US FAERS
1094HypermetabolismFAERS: 1US FAERS
1095Hypertensive emergencyFAERS: 1US FAERS
1096HypervigilanceFAERS: 1US FAERS
1097HypospadiasFAERS: 1US FAERS
1098Hypothalamic pituitary adrenal axis suppressionFAERS: 1US FAERS
1099HypotrichosisFAERS: 1US FAERS
1100HypoventilationFAERS: 1US FAERS
1101HysterectomyFAERS: 1US FAERS
1102Iatrogenic injuryFAERS: 1US FAERS
1103Immune thrombocytopenic purpuraFAERS: 1US FAERS
1104ImmunosuppressionFAERS: 1US FAERS
1105Impaired reasoningFAERS: 1US FAERS
1106ImpetigoFAERS: 1US FAERS
1107Incorrect drug administration durationFAERS: 1US FAERS
1108Incorrect product administration durationFAERS: 1US FAERS
1109Inferiority complexFAERS: 1US FAERS
1110Infrequent bowel movementsFAERS: 1US FAERS
1111Insulin ResistanceFAERS: 1US FAERS
1112Insulin-like growth factor increasedFAERS: 1US FAERS
1113Intentional dose omissionFAERS: 1US FAERS
1114Intercepted product dispensing errorFAERS: 1US FAERS
1115Intervertebral disc disorderFAERS: 1US FAERS
1116Intestinal intraepithelial lymphocytes increasedFAERS: 1US FAERS
1117Intraocular pressure test abnormalFAERS: 1US FAERS
1118IntubationFAERS: 1US FAERS
1119Iodine allergyFAERS: 1US FAERS
1120Irregular breathingFAERS: 1US FAERS
1121Jealous delusionFAERS: 1US FAERS
1122KeratitisFAERS: 1US FAERS
1123KetonuriaFAERS: 1US FAERS
1124LDL/HDL ratio increasedFAERS: 1US FAERS
1125Lack of satietyFAERS: 1US FAERS
1126Lack of spontaneous speechFAERS: 1US FAERS
1127Lacrimation decreasedFAERS: 1US FAERS
1128Large intestine perforationFAERS: 1US FAERS
1129LaryngitisFAERS: 1US FAERS
1130LaryngomalaciaFAERS: 1US FAERS
1131LaryngospasmFAERS: 1US FAERS
1132Left Ventricular HypertrophyFAERS: 1US FAERS
1133LeukocytosisFAERS: 1US FAERS
1134LeukoencephalopathyFAERS: 1US FAERS
1135Levator syndromeFAERS: 1US FAERS
1136Ligament ruptureFAERS: 1US FAERS
1137Light chain analysis abnormalFAERS: 1US FAERS
1138Limb massFAERS: 1US FAERS
1139Lip erythemaFAERS: 1US FAERS
1140LipohypertrophyFAERS: 1US FAERS
1141Liver AbscessFAERS: 1US FAERS
1142Low incomeFAERS: 1US FAERS
1143Lyme DiseaseFAERS: 1US FAERS
1144Lymphocyte count abnormalFAERS: 1US FAERS
1145Lymphoid tissue hyperplasiaFAERS: 1US FAERS
1146MacrocephalyFAERS: 1US FAERS
1147Macular degenerationFAERS: 1US FAERS
1148Malignant neoplasm progressionFAERS: 1US FAERS
1149MalocclusionFAERS: 1US FAERS
1150Manufacturing materials issueFAERS: 1US FAERS
1151MeaslesFAERS: 1US FAERS
1152Mechanical urticariaFAERS: 1US FAERS
1153Mediastinal massFAERS: 1US FAERS
1154Medical device site hypersensitivityFAERS: 1US FAERS
1155Medication tamperingFAERS: 1US FAERS
1156Metastases to pelvisFAERS: 1US FAERS
1157MicrocephalyFAERS: 1US FAERS
1158MicrocytosisFAERS: 1US FAERS
1159MicrogeniaFAERS: 1US FAERS
1160MicrophthalmosFAERS: 1US FAERS
1161Microvascular coronary artery diseaseFAERS: 1US FAERS
1162MiliariaFAERS: 1US FAERS
1163Mixed liver injuryFAERS: 1US FAERS
1164Mixed receptive-expressive language disorderFAERS: 1US FAERS
1165Monoclonal immunoglobulin presentFAERS: 1US FAERS
1166MonoparesisFAERS: 1US FAERS
1167Motion SicknessFAERS: 1US FAERS
1168Mucosal painFAERS: 1US FAERS
1169Muscle hypertrophyFAERS: 1US FAERS
1170Muscle necrosisFAERS: 1US FAERS
1171Muscle tone disorderFAERS: 1US FAERS
1172Muscular DystrophyFAERS: 1US FAERS
1173Mycosis FungoidesFAERS: 1US FAERS
1174Mycotic allergyFAERS: 1US FAERS
1175Myocardial necrosis marker increasedFAERS: 1US FAERS
1176N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
1177Nail discomfortFAERS: 1US FAERS
1178NegativismFAERS: 1US FAERS
1179Neonatal cardiac failureFAERS: 1US FAERS
1180Neonatal hypotensionFAERS: 1US FAERS
1181Neonatal pneumoniaFAERS: 1US FAERS
1182Neonatal respiratory acidosisFAERS: 1US FAERS
1183NeuritisFAERS: 1US FAERS
1184Neuromuscular painFAERS: 1US FAERS
1185NeuropathyFAERS: 1US FAERS
1186Neutrophilic dermatosisFAERS: 1US FAERS
1187No reaction on previous exposure to drugFAERS: 1US FAERS
1188Nodal osteoarthritisFAERS: 1US FAERS
1189Non-cardiac chest painFAERS: 1US FAERS
1190Noninfective bronchitisFAERS: 1US FAERS
1191Noninfective encephalitisFAERS: 1US FAERS
1192Nuchal RigidityFAERS: 1US FAERS
1193Obsessive-Compulsive DisorderFAERS: 1US FAERS
1194Ocular HypertensionFAERS: 1US FAERS
1195OliguriaFAERS: 1US FAERS
1196OnychomalaciaFAERS: 1US FAERS
1197OnychomycosisFAERS: 1US FAERS
1198Opiates positiveFAERS: 1US FAERS
1199Optic NeuritisFAERS: 1US FAERS
1200Oral administration complicationFAERS: 1US FAERS
1201Oral contusionFAERS: 1US FAERS
1202Oral mucosal exfoliationFAERS: 1US FAERS
1203Organic brain syndromeFAERS: 1US FAERS
1204Orthosis userFAERS: 1US FAERS
1205Orthostatic hypertensionFAERS: 1US FAERS
1206Osmolar gap increasedFAERS: 1US FAERS
1207OsteochondrosisFAERS: 1US FAERS
1208OsteopetrosisFAERS: 1US FAERS
1209Otitis MediaFAERS: 1US FAERS
1210Palatal swellingFAERS: 1US FAERS
1211Pancreatic NeoplasmFAERS: 1US FAERS
1212PancreatitisFAERS: 1US FAERS
1213PancytopeniaFAERS: 1US FAERS
1214Paranasal sinus hypersecretionFAERS: 1US FAERS
1215Paranasal sinus mucosal hypertrophyFAERS: 1US FAERS
1216ParaplegiaFAERS: 1US FAERS
1217Pathological doubtFAERS: 1US FAERS
1218Pelvic adhesionsFAERS: 1US FAERS
1219Pelvic discomfortFAERS: 1US FAERS
1220Peripheral arterial occlusive diseaseFAERS: 1US FAERS
1221Peripheral nerve lesionFAERS: 1US FAERS
1222PetechiaeFAERS: 1US FAERS
1223PhagophobiaFAERS: 1US FAERS
1224Pharyngeal swellingFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1225Physical assaultFAERS: 1US FAERS
1226Physical examination abnormalFAERS: 1US FAERS
1227Pituitary enlargementFAERS: 1US FAERS
1228Pityriasis Rubra PilarisFAERS: 1US FAERS
1229Placental InsufficiencyFAERS: 1US FAERS
1230Platelet distribution width increasedFAERS: 1US FAERS
1231Pleuritic painFAERS: 1US FAERS
1232PneumothoraxFAERS: 1US FAERS
1233PolydactylyFAERS: 1US FAERS
1234PolymicrogyriaFAERS: 1US FAERS
1235PolymyositisFAERS: 1US FAERS
1236Poor quality product administeredFAERS: 1US FAERS
1237Portal tract inflammationFAERS: 1US FAERS
1238Post procedural hypothyroidismFAERS: 1US FAERS
1239Post-Traumatic Stress DisorderFAERS: 1US FAERS
1240Precancerous cells presentFAERS: 1US FAERS
1241Pregnancy on contraceptiveFAERS: 1US FAERS
1242Primary Adrenal InsufficiencyFAERS: 1US FAERS
1243Procedural complicationFAERS: 1US FAERS
1244Product barcode issueFAERS: 1US FAERS
1245Product coating issueFAERS: 1US FAERS
1246Product container issueFAERS: 1US FAERS
1247Product contaminationFAERS: 1US FAERS
1248Product distribution issueFAERS: 1US FAERS
1249Product label confusionFAERS: 1US FAERS
1250Product outer packaging issueFAERS: 1US FAERS
1251Product packaging quantity issueFAERS: 1US FAERS
1252Product physical consistency issueFAERS: 1US FAERS
1253Product supply issueFAERS: 1US FAERS
1254Product used for unknown indicationFAERS: 1US FAERS
1255Progesterone decreasedFAERS: 1US FAERS
1256Protein DeficiencyFAERS: 1US FAERS
1257Protein urine presentFAERS: 1US FAERS
1258PrurigoFAERS: 1US FAERS
1259Psychogenic erectile dysfunctionFAERS: 1US FAERS
1260Psychological TraumaFAERS: 1US FAERS
1261Pulmonary InfarctionFAERS: 1US FAERS
1262Pulmonary arterial hypertensionFAERS: 1US FAERS
1263PurpuraFAERS: 1US FAERS
1264QuadriparesisFAERS: 1US FAERS
1265RadiculopathyFAERS: 1US FAERS
1266Rebound psoriasisFAERS: 1US FAERS
1267Red cell distribution width decreasedFAERS: 1US FAERS
1268Rehabilitation therapyFAERS: 1US FAERS
1269Renal dysplasiaFAERS: 1US FAERS
1270Renal tubular necrosisFAERS: 1US FAERS
1271Respiratory tract irritationFAERS: 1US FAERS
1272Resting TremorFAERS: 1US FAERS
1273Restrictive pulmonary diseaseFAERS: 1US FAERS
1274Retinal DetachmentFAERS: 1US FAERS
1275Retinal migraineFAERS: 1US FAERS
1276Reverse tri-iodothyronine decreasedFAERS: 1US FAERS
1277Rheumatic FeverFAERS: 1US FAERS
1278Rheumatoid factor increasedFAERS: 1US FAERS
1279Rheumatoid factor quantitative increasedFAERS: 1US FAERS
1280RhinotracheitisFAERS: 1US FAERS
1281Right ventricular failureFAERS: 1US FAERS
1282Risk of future pregnancy miscarriageFAERS: 1US FAERS
1283SacroiliitisFAERS: 1US FAERS
1284Salivary gland painFAERS: 1US FAERS
1285SalpingitisFAERS: 1US FAERS
1286Scarlet FeverFAERS: 1US FAERS
1287ScleritisFAERS: 1US FAERS
1288SclerodermaFAERS: 1US FAERS
1289Seizure like phenomenaFAERS: 1US FAERS
1290Serum SicknessFAERS: 1US FAERS
1291Sinus painFAERS: 1US FAERS
1292Skeletal dysplasiaFAERS: 1US FAERS
1293Skin IndurationFAERS: 1US FAERS
1294Skin PapillomaFAERS: 1US FAERS
1295Skin UlcerFAERS: 1US FAERS
1296Skin hypertrophyFAERS: 1US FAERS
1297Skin necrosisFAERS: 1US FAERS
1298Skin texture abnormalFAERS: 1US FAERS
1299Skin tightnessFAERS: 1US FAERS
1300Slow speechFAERS: 1US FAERS
1301Specific gravity urine abnormalFAERS: 1US FAERS
1302Spinal cord herniationFAERS: 1US FAERS
1303SplenomegalyFAERS: 1US FAERS
1304SpondylitisFAERS: 1US FAERS
1305Staphylococcal pharyngitisFAERS: 1US FAERS
1306StaringFAERS: 1US FAERS
1307SteatohepatitisFAERS: 1US FAERS
1308Stool analysis abnormalFAERS: 1US FAERS
1309Stool chloride increasedFAERS: 1US FAERS
1310Stool pH decreasedFAERS: 1US FAERS
1311Submandibular massFAERS: 1US FAERS
1312Superinfection bacterialFAERS: 1US FAERS
1313SyndactylyFAERS: 1US FAERS
1314Tablet issueFAERS: 1US FAERS
1315TalipesFAERS: 1US FAERS
1316Teeth brittleFAERS: 1US FAERS
1317TenosynovitisFAERS: 1US FAERS
1318Therapeutic drug monitoring analysis not performedFAERS: 1US FAERS
1319Therapeutic product effect incompleteFAERS: 1US FAERS
1320Therapy non-responderFAERS: 1US FAERS
1321Therapy partial responderFAERS: 1US FAERS
1322Therapy regimen changedFAERS: 1US FAERS
1323Thyroglobulin presentFAERS: 1US FAERS
1324Thyroid cancer metastaticFAERS: 1US FAERS
1325Thyroid cancer stage IVFAERS: 1US FAERS
1326Thyroid dermatopathyFAERS: 1US FAERS
1327Thyroid gland scan abnormalFAERS: 1US FAERS
1328Thyrotoxic cardiomyopathyFAERS: 1US FAERS
1329Thyroxine free normalFAERS: 1US FAERS
1330Tinea CapitisFAERS: 1US FAERS
1331Tinea PedisFAERS: 1US FAERS
1332Tobacco userFAERS: 1US FAERS
1333Tongue eruptionFAERS: 1US FAERS
1334Tongue erythemaFAERS: 1US FAERS
1335Total cholesterol/HDL ratio abnormalFAERS: 1US FAERS
1336TracheitisFAERS: 1US FAERS
1337Tri-iodothyronine uptake abnormalFAERS: 1US FAERS
1338Troponin increasedFAERS: 1US FAERS
1339Ultrasound Doppler abnormalFAERS: 1US FAERS
1340Ultrasound abdomen abnormalFAERS: 1US FAERS
1341Umbilical herniaFAERS: 1US FAERS
1342UnderweightFAERS: 1US FAERS
1343Unmasking of previously unidentified diseaseFAERS: 1US FAERS
1344Upper respiratory tract congestionFAERS: 1US FAERS
1345Urinary sediment presentFAERS: 1US FAERS
1346Urinary tract obstructionFAERS: 1US FAERS
1347Urine albumin/creatinine ratio increasedFAERS: 1US FAERS
1348Urine output increasedFAERS: 1US FAERS
1349Uterine contractions during pregnancyFAERS: 1US FAERS
1350UveitisFAERS: 1US FAERS
1351UvulitisFAERS: 1US FAERS
1352Vanishing bile duct syndromeFAERS: 1US FAERS
1353Varicella Zoster Virus InfectionFAERS: 1US FAERS
1354Vascular compressionFAERS: 1US FAERS
1355Vascular insufficiencyFAERS: 1US FAERS
1356Vascular occlusionFAERS: 1US FAERS
1357Ventricular arrhythmiaFAERS: 1US FAERS
1358Ventricular hyperkinesiaFAERS: 1US FAERS
1359Very low density lipoprotein increasedFAERS: 1US FAERS
1360Vibratory sense increasedFAERS: 1US FAERS
1361Viral myositisFAERS: 1US FAERS
1362Viral upper respiratory tract infectionFAERS: 1US FAERS
1363Visceral congestionFAERS: 1US FAERS
1364Visual acuity reduced transientlyFAERS: 1US FAERS
1365Visual disturbanceFAERS: 1US FAERS
1366Vulvovaginal painFAERS: 1US FAERS
1367Vulvovaginal pruritusFAERS: 1US FAERS
1368Water IntoxicationFAERS: 1US FAERS
1369Water PollutionFAERS: 1US FAERS
1370WeightFAERS: 1US FAERS
1371Wheelchair userFAERS: 1US FAERS
1372Wrong patient received medicationFAERS: 1US FAERS
1373Wrong product administeredFAERS: 1US FAERS
1374pH body fluid abnormalFAERS: 1US FAERS
1375pH urine decreasedFAERS: 1US FAERS
1376Therapeutic product effect variableCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.